Reduction of Proportion of Process‐Bearing Phenotype of Microglial Cell Line MG6 by Arachidonic Acid Generated From Exogenous Lysophosphatidylinositol
Lipids · 2026
DOI: 10.1002/lipd.70012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lipids, 2026. Verfasst von Kohei Kawabata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Microglia, Lysophospholipids, Arachidonic Acid. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Takeda Foundation, Uehara Memorial Foundation.
Abstract (Originalsprache)
Attention has recently been paid to the cross‐talk between G protein‐coupled receptor 55 for lysophosphatidylinositol as an endogenous agonist and cannabinoid receptors 1 and 2 for 2‐arachidonoylglycerol as an endogenous agonists in mammalian neuronal cells. In relation to the functional coupling, in this study, exogenously added 1‐arachidonoyl lysophosphatidylinositol (1–20:4 LPI) to MG6, a mouse microglial cell line, was found to be converted to 1‐arachidonoyl glycerol (1–20:4 MAG) and arachidonic acid (20:4 FFA), possibly due to the combined action of ecto‐lysophospholipaase C activity of glycerophosphodiesterase 3 and extracellular lipase toward MAG. Consistent with the above result, exogenous 1–20:4 MAG was found to be converted to 20:4 FFA by extracellular lipase activity toward MAG in the culture medium of MG6 cells. Not only was exogenous 20:4 FFA incubated with MG6 cells, but also 20:4 FFA produced from the exogenous 1–20:4 MAG and 1–20:4 LPI in the absence of fetal bovine serum, respectively, were postulated to be involved in the reduced population of process‐bearing MG6 cells via its entry into the cells and the intracellular conversion of prostaglandins. This hypothesis was supported by our findings showing that the reducing effects of exogenous 1–20:4 LPI, 1–20:4 MAG, and 20:4 FFA were all found to be indomethacin‐inhibitable, and that exogenous PGD 2 , but not PGE 2 and PGF 2 α, was shown to reduce the population of process‐bearing MG6 cells cultured without Fetal bovine serum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan.
ORCID-Profile: Kohei Kawabata, Akira Tokumura
Förderung
- Japan Society for the Promotion of Science
- Takeda Foundation
- Uehara Memorial Foundation
- Yasuda Women's University
Zitieren
APA
Kawabata, K., Nonaka, S., Hirano, M., Ohtsuki, Y., Inagaki, M., Nakanishi, H., Nishi, H., & Tokumura, A. (2026). Reduction of Proportion of Process‐Bearing Phenotype of Microglial Cell Line MG6 by Arachidonic Acid Generated From Exogenous Lysophosphatidylinositol. Lipids. https://doi.org/10.1002/lipd.70012
Vancouver
Kawabata K, Nonaka S, Hirano M, Ohtsuki Y, Inagaki M, Nakanishi H, et al. Reduction of Proportion of Process‐Bearing Phenotype of Microglial Cell Line MG6 by Arachidonic Acid Generated From Exogenous Lysophosphatidylinositol. Lipids. 2026. doi:10.1002/lipd.70012
BibTeX
@article{Kawabata2026,
author = {Kawabata, Kohei and Nonaka, Saori and Hirano, Makoto and Ohtsuki, Yuya and Inagaki, Masanori and Nakanishi, Hiroshi and Nishi, Hiroyuki and Tokumura, Akira},
title = {Reduction of Proportion of Process‐Bearing Phenotype of Microglial Cell Line MG6 by Arachidonic Acid Generated From Exogenous Lysophosphatidylinositol},
journal = {Lipids},
year = {2026},
doi = {10.1002/lipd.70012}
}
EUVIMED